Recs

3

Buy Out or Sell Out?

From tiny acquisitions to massive conglomerate combinations, Wall Street's urge to merge remains strong. Some of these deals might generate sought-after synergy, but others could create what Peter Lynch called "diworsification" -- weakening a business's core competency by grafting on wildly unrelated subsidiaries. How can we tell the good deals from the deal breakers?

Breaking down the buildup
To help, we'll turn to the 97,000 investors in Motley Fool CAPS. A combination of two companies with high CAPS ratings might bode well for the new firm's future results, while a highly-rated company that joins a lower-rated one may benefit one set of investors more than the other.

Despite troubles in the capital markets, the deals won't stop; they simply might involve more stock and less cash. Here's a handful of recently announced deals, and the ratings for each participating company on CAPS' five-star scale:

Acquirer

CAPS Rating

Target

CAPS Rating

Deal Price

Navigant Consulting

***

Chicago Partners

NR

$73 million

Blue Coat Systems (:BCSI)

****

Packeteer (NASDAQ:PKTR)

**

$268 million

Avnet

****

Horizon Technology Group

NR

$150 million

Liberty Mutual

NR

Safeco (:SAF)

***

$6.12 billion

GlaxoSmithKline (NYSE:GSK)

****

Sirtris Pharmaceuticals (NASDAQ:SIRT)

***

$720 million

CAPS ratings courtesy of Motley Fool CAPS; NR = not rated.

A bear of a time
Although there seem to be a greater number of deals pending, in fact the first quarter's $736 billion is the smallest global dollar value amount in six years. The total number of deals is up 14%, to more than 9,100 deals, they're just worth less. The main reason is the 41% decline in U.S. deal values, down to $203 billion, though some of the slack has been made up in both Russia (up 173% to $33 billion) and China (up 43% to $35 billion).

A cavalcade of treatments
There have been a few stumbles over the past year or so when Blue Coat started to bleed red, but the security appliance developer has increasingly focused on wide-area networking (WAN) markets and has seen a number of successful initiatives that are leading to growing revenue. It has also partnered with companies including Symantec (Nasdaq: SYMC  ) and McAfee to offer antivirus technology, and with Websense to offer content filtering. As Blue Coat likes to say, its proxy gateways police traffic so as to "keep 'good' employees from doing 'bad' things on the Internet."

WAN optimization and Web acceleration combinations are becoming a more crowded field, however. Both F5 and Riverbed (Nasdaq: RVBD  ) are increasingly shifting their attention to WANs. The addition of Packeteer ought to help Blue Coat fend off those challenges.

Citing Packeteer's own issues, CAPS investor Blindnomore saw the attempt by Elliott Partners to make an unsolicited acquisition as not in the best interest of shareholders, though a Blue Coat bid might be seen as more beneficial.

Unjustly beaten down by the IRS and now the recent target of a hostile takeover by a beneficial owner, [Packeteer] shareholders fend off the hostile bid because they know that the company has much more value than has been showing up in share price. With too many big contracts to count, one with Microsoft as their first networking optimization software for network traffic. BIG.

A value-added offer
What's your take on these deals? At Motley Fool CAPS, your opinion is as valuable as the pros'. Tell the CAPS community whether the urge to merge is good to go -- or whether you think it's better for the firms involved to remain independent.

Best Odds in the Universe!
If you're interested in a 98.79% chance at beating the market... and a 70.84% chance at DOUBLING the market's return – Motley Fool Supernova could be just what you're looking for. And get this: We arrived at these odds from 10,000 random back-tested portfolios composed of Motley Fool Co-founder David Gardner's personal stock picks.

It's why David recently handpicked a small team of world-class portfolio managers. You see, he thinks these odds can get even better! And he'd like to prove it to you...

Simply enter your email address. And the answer to the question everybody is asking will be delivered to your inbox!


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 628098, ~/Articles/ArticleHandler.aspx, 2/14/2012 11:00:24 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 12,824.31 -49.73 -0.39%
S&P 500 1,346.29 -5.48 -0.41%
NASD 2,918.66 -12.73 -0.43%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

2/14/2012 10:10 AM
SYMC $17.85 Down -0.08 -0.45%
Symantec Corp CAPS Rating: **
GSK $45.31 Down -0.12 -0.26%
GlaxoSmithKline CAPS Rating: ****
BCSI $25.79 Up +0.01 +0.04%
Blue Coat Systems,… CAPS Rating: **

Advertisement